Cushing’s Syndrome Market to Grow Rapidly During the Forecast Period – DelveInsight | Key Companies – Cortendo, Recordati, Millendo Therapeutics, HRA Pharma, Corcept Therapeutics, and SteroTherapeutics

April 25 23:06 2022
Cushing's Syndrome Market to Grow Rapidly During the Forecast Period - DelveInsight | Key Companies - Cortendo, Recordati, Millendo Therapeutics, HRA Pharma, Corcept Therapeutics, and SteroTherapeutics
Delveinsight Business Research LLP
DelveInsight’s “Cushing’s Syndrome Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Cushing’s Syndrome Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Cushing’s Syndrome market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Cushing's Syndrome Market

Cushing’s Syndrome: An Overview

Cushing syndrome occurs when a patient’s body is exposed to high levels of the hormone cortisol over a long period of time (chronic hypercortisolemia). Too much cortisol can produce some of the hallmark signs of Cushing syndrome — a fatty hump between a patient’s shoulders, a rounded face, and pink or purple stretch marks on the skin.

As per the Endocrine Society, Cushing’s Syndrome affects fewer than five in 10,000 individuals. The symptoms of Cushing’s Syndrome may vary, but most people have central (upper body) obesity, rounded face, increased fat around the neck, and thin arms and legs. Children with this disease are observed to have a slower growth rate.

Cushing’s Syndrome Market Key Facts

  • According to the Orphanet, the prevalence of endogenous Cushing’s Syndrome (CS) is 1/26,000 and, in the EU, it has an annual prevalence of 1/1,400,000-1/400,000, with a peak prevalence at 25-40 years of age.

  • As per the National Organization for Rare Disorders, although it may occur in children, Cushing’s syndrome most commonly affects adults between the ages of 25 to 40.

  • As per the National Organization for Rare Disorders, Cushing’s syndrome caused by either an adrenal or pituitary tumor affects females five times more frequently than males. Cushing’s Syndrome’s symptoms commonly begin between 25 to 40 years of age.

Cushing’s Syndrome Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Cushing’s Syndrome market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Cushing’s Syndrome market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Cushing’s Syndrome Epidemiology

The epidemiology section covers insights into the historical and current Cushing’s Syndrome patient pool and forecasted trends for every seven major countries (7MM)  from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool, future trends, and assumptions undertaken.

Cushing’s Syndrome Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cushing’s Syndrome market or expected to get launched during the study period. The analysis covers Cushing’s Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Cushing’s Syndrome Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report –

Cushing’s Syndrome Therapeutics Analysis

The Cushing’s Syndrome market dynamics is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the diseases, incremental healthcare spending across the world, and the expected launch of the emerging therapies.

Some of the key companies in the Cushing’s Syndrome Market include:

  • Recordati

  • Corcept Therapeutics

  • Millendo Therapeutics

  • Cortendo

  • SteroTherapeutics

  • HRA Pharma

And many others

Cushing’s Syndrome therapies covered in the report include:

  • Mifepristone (Korlym)

  • Pasireotide (Signifor)

  • Osilodrostat

  • Relacorilant

And many more.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Cushing’s Syndrome Competitive Intelligence Analysis

4. Cushing’s Syndrome Market Overview at a Glance

5. Cushing’s Syndrome Disease Background and Overview

6. Cushing’s Syndrome Patient Journey

7. Cushing’s Syndrome Epidemiology and Patient Population

8. Cushing’s Syndrome Treatment Algorithm, Current Treatment, and Medical Practices

9. Cushing’s Syndrome Unmet Needs

10. Key Endpoints of Cushing’s Syndrome Treatment

11. Cushing’s Syndrome Marketed Products

12. Cushing’s Syndrome Emerging Therapies

13. Cushing’s Syndrome Seven Major Market Analysis

14. Attribute Analysis

15. Cushing’s Syndrome Market Outlook (7 major markets)

16. Cushing’s Syndrome Access and Reimbursement Overview

17. KOL Views on the Cushing’s Syndrome Market.

18. Cushing’s Syndrome Market Drivers

19. Cushing’s Syndrome Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance. 

Other Latest Reports By DelveInsight

Global Kinase Inhibitor in Autoimmune Diseases Market

DelveInsight’s “Global Kinase Inhibitor in Autoimmune Diseases Market” report delivers an in-depth understanding of the diseases, historical and forecasted epidemiology as well as the Global Kinase Inhibitor in Autoimmune Diseases market trends in 7MM.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States